

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.85734417 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.85734417 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.82715969 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.87506312 |
| 5 | DNA deamination (GO:0045006) | 4.42596362 |
| 6 | cytidine deamination (GO:0009972) | 4.41283329 |
| 7 | cytidine metabolic process (GO:0046087) | 4.41283329 |
| 8 | cytidine catabolic process (GO:0006216) | 4.41283329 |
| 9 | type I interferon signaling pathway (GO:0060337) | 4.30726166 |
| 10 | cellular response to type I interferon (GO:0071357) | 4.30726166 |
| 11 | response to type I interferon (GO:0034340) | 4.29308510 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 4.04417675 |
| 13 | cellular response to interferon-beta (GO:0035458) | 3.90579562 |
| 14 | response to interferon-beta (GO:0035456) | 3.87406038 |
| 15 | positive regulation of antigen processing and presentation (GO:0002579) | 3.84450177 |
| 16 | NIK/NF-kappaB signaling (GO:0038061) | 3.84305049 |
| 17 | ribosomal small subunit assembly (GO:0000028) | 3.83392091 |
| 18 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.79207353 |
| 19 | regulation of RIG-I signaling pathway (GO:0039535) | 3.78509312 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 3.76824034 |
| 21 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.63642143 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 3.61084957 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.56783733 |
| 24 | regulation of interferon-alpha production (GO:0032647) | 3.56717022 |
| 25 | cellular response to zinc ion (GO:0071294) | 3.55758416 |
| 26 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.54288565 |
| 27 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.47911920 |
| 28 | regulation of antigen processing and presentation (GO:0002577) | 3.45086617 |
| 29 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.43068543 |
| 30 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.42757497 |
| 31 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.38177316 |
| 32 | response to peptidoglycan (GO:0032494) | 3.37846590 |
| 33 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.37030916 |
| 34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.33969019 |
| 35 | myeloid dendritic cell activation (GO:0001773) | 3.33864682 |
| 36 | B cell mediated immunity (GO:0019724) | 3.31447134 |
| 37 | myeloid dendritic cell differentiation (GO:0043011) | 3.30035084 |
| 38 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.28394853 |
| 39 | respiratory burst (GO:0045730) | 3.23399142 |
| 40 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.23308805 |
| 41 | * regulation of cellular amino acid metabolic process (GO:0006521) | 3.22128107 |
| 42 | ATP synthesis coupled proton transport (GO:0015986) | 3.21246899 |
| 43 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.21246899 |
| 44 | T cell migration (GO:0072678) | 3.20189273 |
| 45 | defense response to protozoan (GO:0042832) | 3.19826340 |
| 46 | negative regulation of viral genome replication (GO:0045071) | 3.19295373 |
| 47 | negative thymic T cell selection (GO:0045060) | 3.17905621 |
| 48 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.17843180 |
| 49 | response to interferon-alpha (GO:0035455) | 3.17820096 |
| 50 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.17723962 |
| 51 | * DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.16733463 |
| 52 | regulation of regulatory T cell differentiation (GO:0045589) | 3.15255985 |
| 53 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.14655752 |
| 54 | * negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.14188789 |
| 55 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.10522392 |
| 56 | positive regulation of interleukin-12 production (GO:0032735) | 3.10225301 |
| 57 | granulocyte activation (GO:0036230) | 3.08579569 |
| 58 | sequestering of actin monomers (GO:0042989) | 3.08384399 |
| 59 | * intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.06970196 |
| 60 | * signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.06970196 |
| 61 | positive thymic T cell selection (GO:0045059) | 3.06221939 |
| 62 | neutrophil activation (GO:0042119) | 3.06213391 |
| 63 | natural killer cell mediated immunity (GO:0002228) | 3.05750536 |
| 64 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.05750536 |
| 65 | * antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.05231617 |
| 66 | negative T cell selection (GO:0043383) | 3.05225480 |
| 67 | * signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.04481114 |
| 68 | * signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.04481114 |
| 69 | * signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.04481114 |
| 70 | cellular response to exogenous dsRNA (GO:0071360) | 3.04243459 |
| 71 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.99900593 |
| 72 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.94316116 |
| 73 | regulation of T cell tolerance induction (GO:0002664) | 2.92849948 |
| 74 | * signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.91464169 |
| 75 | * signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.91464169 |
| 76 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.91169801 |
| 77 | * positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.90151057 |
| 78 | regulation of hypersensitivity (GO:0002883) | 2.89259286 |
| 79 | T-helper 1 type immune response (GO:0042088) | 2.89051870 |
| 80 | leukocyte aggregation (GO:0070486) | 2.88270754 |
| 81 | * negative regulation of ligase activity (GO:0051352) | 2.88038143 |
| 82 | * negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.88038143 |
| 83 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.87666172 |
| 84 | regulation of chronic inflammatory response (GO:0002676) | 2.87593925 |
| 85 | response to protozoan (GO:0001562) | 2.87060046 |
| 86 | regulation of activation of Janus kinase activity (GO:0010533) | 2.86677716 |
| 87 | * antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.86268300 |
| 88 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.86019543 |
| 89 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.85526796 |
| 90 | cellular response to interleukin-15 (GO:0071350) | 2.85486516 |
| 91 | * signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.82658485 |
| 92 | viral transcription (GO:0019083) | 2.81990190 |
| 93 | T cell costimulation (GO:0031295) | 2.81757415 |
| 94 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.80814661 |
| 95 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.79915492 |
| 96 | lymphocyte costimulation (GO:0031294) | 2.79830326 |
| 97 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.77867124 |
| 98 | reactive oxygen species biosynthetic process (GO:1903409) | 2.75350575 |
| 99 | dendritic cell differentiation (GO:0097028) | 2.75154477 |
| 100 | regulation of immunoglobulin secretion (GO:0051023) | 2.74329353 |
| 101 | positive regulation of interferon-beta production (GO:0032728) | 2.74258238 |
| 102 | positive regulation of lymphocyte migration (GO:2000403) | 2.74175334 |
| 103 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.73603181 |
| 104 | negative regulation of cell killing (GO:0031342) | 2.73603181 |
| 105 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.73304077 |
| 106 | positive regulation of type 2 immune response (GO:0002830) | 2.72934334 |
| 107 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.72763059 |
| 108 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.72730942 |
| 109 | response to muramyl dipeptide (GO:0032495) | 2.72374853 |
| 110 | * regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.70869839 |
| 111 | cellular response to virus (GO:0098586) | 2.70327051 |
| 112 | cellular response to interferon-gamma (GO:0071346) | 2.70213469 |
| 113 | response to interleukin-15 (GO:0070672) | 2.69945745 |
| 114 | regulation of response to interferon-gamma (GO:0060330) | 2.69604673 |
| 115 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.68656218 |
| 116 | respiratory electron transport chain (GO:0022904) | 2.68646533 |
| 117 | translational termination (GO:0006415) | 2.68191169 |
| 118 | positive regulation of humoral immune response (GO:0002922) | 2.67603236 |
| 119 | proteasome assembly (GO:0043248) | 2.66992969 |
| 120 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.64759939 |
| 121 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.64438409 |
| 122 | leukocyte mediated cytotoxicity (GO:0001909) | 2.64159608 |
| 123 | regulation of chemokine biosynthetic process (GO:0045073) | 2.62926810 |
| 124 | electron transport chain (GO:0022900) | 2.62642796 |
| 125 | modulation by symbiont of host immune response (GO:0052553) | 2.61996203 |
| 126 | positive regulation by symbiont of host defense response (GO:0052509) | 2.61996203 |
| 127 | modulation by symbiont of host defense response (GO:0052031) | 2.61996203 |
| 128 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.61996203 |
| 129 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.61996203 |
| 130 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.61996203 |
| 131 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.60873754 |
| 132 | response to interferon-gamma (GO:0034341) | 2.60422730 |
| 133 | positive regulation of B cell differentiation (GO:0045579) | 2.58629116 |
| 134 | regulation of interleukin-12 production (GO:0032655) | 2.58302661 |
| 135 | actin nucleation (GO:0045010) | 2.57897305 |
| 136 | regulation of viral genome replication (GO:0045069) | 2.57584531 |
| 137 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.56797290 |
| 138 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.56052767 |
| 139 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.55857473 |
| 140 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.54229257 |
| 141 | positive regulation of interleukin-2 production (GO:0032743) | 2.53987776 |
| 142 | monocyte chemotaxis (GO:0002548) | 2.53434915 |
| 143 | mast cell activation (GO:0045576) | 2.53023944 |
| 144 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.52895018 |
| 145 | lymphocyte chemotaxis (GO:0048247) | 2.52293946 |
| 146 | positive regulation of T cell migration (GO:2000406) | 2.51881362 |
| 147 | negative regulation of interleukin-12 production (GO:0032695) | 2.51677760 |
| 148 | positive regulation of isotype switching (GO:0045830) | 2.51313466 |
| 149 | detection of bacterium (GO:0016045) | 2.51208820 |
| 150 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.50918843 |
| 151 | regulation of natural killer cell differentiation (GO:0032823) | 2.50522320 |
| 152 | positive regulation of defense response to virus by host (GO:0002230) | 2.49430097 |
| 153 | natural killer cell activation (GO:0030101) | 2.49236190 |
| 154 | regulation of tolerance induction (GO:0002643) | 2.48108495 |
| 155 | regulation of gamma-delta T cell activation (GO:0046643) | 2.46507634 |
| 156 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.46304744 |
| 157 | positive T cell selection (GO:0043368) | 2.46139201 |
| 158 | * anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.45688419 |
| 159 | thymic T cell selection (GO:0045061) | 2.45188068 |
| 160 | positive regulation of B cell mediated immunity (GO:0002714) | 2.41572075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.40762814 |
| 2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.85416816 |
| 3 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.50966647 |
| 4 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.26483373 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.41269648 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.33611016 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.94354146 |
| 8 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.94003599 |
| 9 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.85415903 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.75282285 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.65597560 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.52455949 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.47084179 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39135406 |
| 15 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.38179685 |
| 16 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.36987733 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.32321529 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.22008212 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.21570646 |
| 20 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.17510695 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.16645258 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.14391903 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.09177770 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03592441 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.91706931 |
| 26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.88149063 |
| 27 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.86118839 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 1.84231191 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.83668723 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.80142233 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79180122 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.67632369 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63058704 |
| 34 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.60313036 |
| 35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.59615055 |
| 36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57570859 |
| 37 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.54390532 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.53988275 |
| 39 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.53320837 |
| 40 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.52546909 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.50301751 |
| 42 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.49325968 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46926893 |
| 44 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.45739484 |
| 45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.44491262 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41423025 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40685282 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.40682442 |
| 49 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.40336388 |
| 50 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.40235906 |
| 51 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.39931258 |
| 52 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.39118628 |
| 53 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.38802492 |
| 54 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.36597165 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.36234896 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35220927 |
| 57 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.34545837 |
| 58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32993136 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32291008 |
| 60 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.29666302 |
| 61 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.29380590 |
| 62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29254237 |
| 63 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.27872811 |
| 64 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.27827805 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27537906 |
| 66 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.24455630 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23758265 |
| 68 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.23333617 |
| 69 | UTX_26944678_Chip-Seq_JUKART_Human | 1.21053973 |
| 70 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.20478911 |
| 71 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20150460 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.19049738 |
| 73 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.18849878 |
| 74 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.17960332 |
| 75 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17334289 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16032197 |
| 77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16021625 |
| 78 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.15494413 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15339586 |
| 80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13442579 |
| 81 | MYC_22102868_ChIP-Seq_BL_Human | 1.12158776 |
| 82 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.10412675 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09485662 |
| 84 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.08737604 |
| 85 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.07728527 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07339156 |
| 87 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.06102195 |
| 88 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05708772 |
| 89 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04791816 |
| 90 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.04342317 |
| 91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03138314 |
| 92 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.02912438 |
| 93 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02900683 |
| 94 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.02591397 |
| 95 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.02011344 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01992637 |
| 97 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01147174 |
| 98 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.00637070 |
| 99 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.00154967 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99265831 |
| 101 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99016800 |
| 102 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.98453799 |
| 103 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98134493 |
| 104 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96359138 |
| 105 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95805098 |
| 106 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95205323 |
| 107 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.94078797 |
| 108 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93842929 |
| 109 | * XRN2_22483619_ChIP-Seq_HELA_Human | 0.92557859 |
| 110 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91340224 |
| 111 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.90911082 |
| 112 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90394858 |
| 113 | P300_27268052_Chip-Seq_Bcells_Human | 0.89614020 |
| 114 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89502460 |
| 115 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.88927690 |
| 116 | SPI1_23127762_ChIP-Seq_K562_Human | 0.86887834 |
| 117 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.86805823 |
| 118 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.86319242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001835_abnormal_antigen_presentation | 4.83265226 |
| 2 | MP0009785_altered_susceptibility_to | 3.89263537 |
| 3 | MP0000685_abnormal_immune_system | 3.63338104 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.42025631 |
| 5 | MP0005671_abnormal_response_to | 3.33229962 |
| 6 | MP0003436_decreased_susceptibility_to | 3.20538896 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.96785981 |
| 8 | MP0005025_abnormal_response_to | 2.96083417 |
| 9 | MP0001790_abnormal_immune_system | 2.95876302 |
| 10 | MP0005387_immune_system_phenotype | 2.95876302 |
| 11 | MP0003724_increased_susceptibility_to | 2.95253326 |
| 12 | MP0006082_CNS_inflammation | 2.80961877 |
| 13 | MP0001800_abnormal_humoral_immune | 2.66622922 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.54183265 |
| 15 | MP0002419_abnormal_innate_immunity | 2.52522386 |
| 16 | MP0002723_abnormal_immune_serum | 2.51812898 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.36886547 |
| 18 | * MP0001819_abnormal_immune_cell | 2.32874296 |
| 19 | * MP0002420_abnormal_adaptive_immunity | 2.30078204 |
| 20 | MP0001853_heart_inflammation | 2.21001782 |
| 21 | MP0002139_abnormal_hepatobiliary_system | 2.15030176 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.00175138 |
| 23 | MP0004510_myositis | 1.99989706 |
| 24 | MP0010155_abnormal_intestine_physiology | 1.97503022 |
| 25 | * MP0002166_altered_tumor_susceptibility | 1.92647562 |
| 26 | MP0002405_respiratory_system_inflammati | 1.92561927 |
| 27 | * MP0002006_tumorigenesis | 1.90830508 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.85641297 |
| 29 | MP0000716_abnormal_immune_system | 1.85293816 |
| 30 | MP0002398_abnormal_bone_marrow | 1.85107883 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.80999415 |
| 32 | MP0004947_skin_inflammation | 1.79818629 |
| 33 | MP0008469_abnormal_protein_level | 1.70262678 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.68394299 |
| 35 | MP0005310_abnormal_salivary_gland | 1.67243304 |
| 36 | MP0001873_stomach_inflammation | 1.64537930 |
| 37 | MP0009764_decreased_sensitivity_to | 1.63173066 |
| 38 | MP0003186_abnormal_redox_activity | 1.61743691 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.58869459 |
| 40 | MP0002163_abnormal_gland_morphology | 1.56417671 |
| 41 | MP0002429_abnormal_blood_cell | 1.53704172 |
| 42 | MP0002254_reproductive_system_inflammat | 1.50374050 |
| 43 | MP0001348_abnormal_lacrimal_gland | 1.49530521 |
| 44 | MP0002722_abnormal_immune_system | 1.47439651 |
| 45 | MP0000689_abnormal_spleen_morphology | 1.46662052 |
| 46 | MP0003303_peritoneal_inflammation | 1.46653712 |
| 47 | MP0000858_altered_metastatic_potential | 1.41666017 |
| 48 | MP0003448_altered_tumor_morphology | 1.33406271 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.28936109 |
| 50 | MP0008875_abnormal_xenobiotic_pharmacok | 1.25078145 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.24523158 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 1.19990756 |
| 53 | MP0001666_abnormal_nutrient_absorption | 1.18319954 |
| 54 | MP0004782_abnormal_surfactant_physiolog | 1.17833786 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.17660826 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.17660826 |
| 57 | MP0003866_abnormal_defecation | 1.17509029 |
| 58 | MP0002396_abnormal_hematopoietic_system | 1.16292758 |
| 59 | MP0005365_abnormal_bile_salt | 1.14170063 |
| 60 | MP0000490_abnormal_crypts_of | 1.13500203 |
| 61 | MP0005075_abnormal_melanosome_morpholog | 1.13340652 |
| 62 | MP0000343_altered_response_to | 1.11879509 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 1.09741400 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.04949447 |
| 65 | MP0003786_premature_aging | 1.04579077 |
| 66 | MP0000703_abnormal_thymus_morphology | 1.04531058 |
| 67 | MP0001346_abnormal_lacrimal_gland | 1.04203205 |
| 68 | MP0002933_joint_inflammation | 1.02152181 |
| 69 | MP0005085_abnormal_gallbladder_physiolo | 1.01128453 |
| 70 | MP0009763_increased_sensitivity_to | 1.01060474 |
| 71 | MP0003693_abnormal_embryo_hatching | 0.96018410 |
| 72 | MP0009840_abnormal_foam_cell | 0.95756553 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 0.94227333 |
| 74 | MP0003252_abnormal_bile_duct | 0.92067791 |
| 75 | MP0002132_abnormal_respiratory_system | 0.90032234 |
| 76 | MP0003300_gastrointestinal_ulcer | 0.89446386 |
| 77 | MP0002998_abnormal_bone_remodeling | 0.86473428 |
| 78 | MP0005379_endocrine/exocrine_gland_phen | 0.84987593 |
| 79 | MP0000604_amyloidosis | 0.82859498 |
| 80 | MP0002019_abnormal_tumor_incidence | 0.82485908 |
| 81 | MP0005332_abnormal_amino_acid | 0.80541169 |
| 82 | MP0008057_abnormal_DNA_replication | 0.80469251 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 0.78503334 |
| 84 | MP0008872_abnormal_physiological_respon | 0.76476355 |
| 85 | MP0005636_abnormal_mineral_homeostasis | 0.75281587 |
| 86 | MP0000372_irregular_coat_pigmentation | 0.75255596 |
| 87 | MP0001764_abnormal_homeostasis | 0.74502485 |
| 88 | MP0003075_altered_response_to | 0.73737496 |
| 89 | MP0004019_abnormal_vitamin_homeostasis | 0.73440486 |
| 90 | MP0005165_increased_susceptibility_to | 0.73350074 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 0.72329015 |
| 92 | MP0005645_abnormal_hypothalamus_physiol | 0.71883990 |
| 93 | MP0010307_abnormal_tumor_latency | 0.71720208 |
| 94 | MP0002876_abnormal_thyroid_physiology | 0.70489419 |
| 95 | MP0003172_abnormal_lysosome_physiology | 0.70068545 |
| 96 | MP0003806_abnormal_nucleotide_metabolis | 0.69294850 |
| 97 | MP0000609_abnormal_liver_physiology | 0.68817561 |
| 98 | MP0005390_skeleton_phenotype | 0.68527606 |
| 99 | MP0004147_increased_porphyrin_level | 0.68110424 |
| 100 | MP0000465_gastrointestinal_hemorrhage | 0.68029553 |
| 101 | MP0005174_abnormal_tail_pigmentation | 0.67763969 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 0.67717447 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.67664862 |
| 104 | MP0005451_abnormal_body_composition | 0.66594187 |
| 105 | MP0005166_decreased_susceptibility_to | 0.66318355 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.65859414 |
| 107 | MP0009643_abnormal_urine_homeostasis | 0.65496053 |
| 108 | MP0000249_abnormal_blood_vessel | 0.65304377 |
| 109 | MP0009278_abnormal_bone_marrow | 0.64655445 |
| 110 | MP0005360_urolithiasis | 0.63844517 |
| 111 | MP0002693_abnormal_pancreas_physiology | 0.63589937 |
| 112 | MP0001881_abnormal_mammary_gland | 0.63315550 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.63021556 |
| 114 | MP0008873_increased_physiological_sensi | 0.62952821 |
| 115 | MP0001663_abnormal_digestive_system | 0.62940741 |
| 116 | MP0009379_abnormal_foot_pigmentation | 0.62736243 |
| 117 | MP0005164_abnormal_response_to | 0.61339829 |
| 118 | MP0002009_preneoplasia | 0.60499412 |
| 119 | MP0003195_calcinosis | 0.59955297 |
| 120 | MP0009765_abnormal_xenobiotic_induced | 0.57383814 |
| 121 | MP0006054_spinal_hemorrhage | 0.56077190 |
| 122 | MP0000598_abnormal_liver_morphology | 0.53622991 |
| 123 | MP0001851_eye_inflammation | 0.52317872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.50347641 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.29443118 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.19423811 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.86124686 |
| 5 | Increased IgM level (HP:0003496) | 4.70678436 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 4.55455941 |
| 7 | Chronic otitis media (HP:0000389) | 4.24086613 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.03419509 |
| 9 | Myositis (HP:0100614) | 3.99027440 |
| 10 | Recurrent fungal infections (HP:0002841) | 3.84219747 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.66197320 |
| 12 | Recurrent skin infections (HP:0001581) | 3.54450835 |
| 13 | Recurrent viral infections (HP:0004429) | 3.54436806 |
| 14 | Abnormality of macrophages (HP:0004311) | 3.51264684 |
| 15 | Recurrent bronchitis (HP:0002837) | 3.44956627 |
| 16 | Vasculitis (HP:0002633) | 3.40116997 |
| 17 | Thrombocytosis (HP:0001894) | 3.36691852 |
| 18 | Orchitis (HP:0100796) | 3.36242053 |
| 19 | Abnormality of T cell number (HP:0011839) | 3.30109057 |
| 20 | Hypergammaglobulinemia (HP:0010702) | 3.30009904 |
| 21 | Autoimmune hemolytic anemia (HP:0001890) | 3.26999728 |
| 22 | Mitochondrial inheritance (HP:0001427) | 3.25400686 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.25025930 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.25025930 |
| 25 | Abnormality of T cell physiology (HP:0011840) | 3.20867875 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.19730725 |
| 27 | Optic neuritis (HP:0100653) | 3.19730725 |
| 28 | Nasal polyposis (HP:0100582) | 3.15711213 |
| 29 | Acute necrotizing encephalopathy (HP:0006965) | 3.15350107 |
| 30 | Abnormality of T cells (HP:0002843) | 3.12701553 |
| 31 | Pustule (HP:0200039) | 3.04683387 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.03912272 |
| 33 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.99621835 |
| 34 | Abnormality of B cell number (HP:0010975) | 2.94809703 |
| 35 | Hepatocellular necrosis (HP:0001404) | 2.93073820 |
| 36 | Aplastic anemia (HP:0001915) | 2.91577991 |
| 37 | Basal ganglia calcification (HP:0002135) | 2.91201498 |
| 38 | Increased CSF lactate (HP:0002490) | 2.90361372 |
| 39 | Gingivitis (HP:0000230) | 2.89628326 |
| 40 | Petechiae (HP:0000967) | 2.88654116 |
| 41 | Stomatitis (HP:0010280) | 2.85631559 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 2.84670307 |
| 43 | Increased hepatocellular lipid droplets (HP:0006565) | 2.84633975 |
| 44 | Hepatic necrosis (HP:0002605) | 2.83305218 |
| 45 | Abnormality of the nasal mucosa (HP:0000433) | 2.82708341 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.81427859 |
| 47 | Obstructive lung disease (HP:0006536) | 2.81427859 |
| 48 | T lymphocytopenia (HP:0005403) | 2.80479567 |
| 49 | Acute encephalopathy (HP:0006846) | 2.75863629 |
| 50 | Vacuolated lymphocytes (HP:0001922) | 2.72620715 |
| 51 | Meningitis (HP:0001287) | 2.71302046 |
| 52 | B lymphocytopenia (HP:0010976) | 2.70486167 |
| 53 | Eosinophilia (HP:0001880) | 2.70198734 |
| 54 | Increased intramyocellular lipid droplets (HP:0012240) | 2.67434424 |
| 55 | IgG deficiency (HP:0004315) | 2.66497573 |
| 56 | Lipid accumulation in hepatocytes (HP:0006561) | 2.66495608 |
| 57 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.65478389 |
| 58 | Interstitial pulmonary disease (HP:0006530) | 2.65283752 |
| 59 | Progressive macrocephaly (HP:0004481) | 2.61534142 |
| 60 | IgM deficiency (HP:0002850) | 2.61184380 |
| 61 | Urticaria (HP:0001025) | 2.60599852 |
| 62 | Joint swelling (HP:0001386) | 2.59997328 |
| 63 | Leukocytosis (HP:0001974) | 2.59712067 |
| 64 | Granulocytopenia (HP:0001913) | 2.59620892 |
| 65 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.58242083 |
| 66 | Periodontitis (HP:0000704) | 2.57837150 |
| 67 | Renal Fanconi syndrome (HP:0001994) | 2.52988157 |
| 68 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.51264543 |
| 69 | Pulmonary infiltrates (HP:0002113) | 2.51198289 |
| 70 | Combined immunodeficiency (HP:0005387) | 2.50384281 |
| 71 | Systemic lupus erythematosus (HP:0002725) | 2.49272693 |
| 72 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.49013868 |
| 73 | Severe combined immunodeficiency (HP:0004430) | 2.46897314 |
| 74 | Chronic sinusitis (HP:0011109) | 2.45391383 |
| 75 | Abnormal number of erythroid precursors (HP:0012131) | 2.44440154 |
| 76 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.43686469 |
| 77 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.43686469 |
| 78 | 3-Methylglutaconic aciduria (HP:0003535) | 2.42538101 |
| 79 | Increased muscle lipid content (HP:0009058) | 2.39173431 |
| 80 | Abnormality of eosinophils (HP:0001879) | 2.38910060 |
| 81 | Hemoptysis (HP:0002105) | 2.36614117 |
| 82 | Reticulocytopenia (HP:0001896) | 2.35387215 |
| 83 | Recurrent pneumonia (HP:0006532) | 2.34089465 |
| 84 | Lymphopenia (HP:0001888) | 2.34075773 |
| 85 | Gingival bleeding (HP:0000225) | 2.33688737 |
| 86 | Agammaglobulinemia (HP:0004432) | 2.32409353 |
| 87 | Hypoproteinemia (HP:0003075) | 2.31398719 |
| 88 | Cerebral edema (HP:0002181) | 2.30677497 |
| 89 | Panhypogammaglobulinemia (HP:0003139) | 2.27114176 |
| 90 | Exertional dyspnea (HP:0002875) | 2.25060514 |
| 91 | Generalized aminoaciduria (HP:0002909) | 2.24483778 |
| 92 | Recurrent lower respiratory tract infections (HP:0002783) | 2.24227443 |
| 93 | Cellulitis (HP:0100658) | 2.22811664 |
| 94 | Purpura (HP:0000979) | 2.22379352 |
| 95 | Chronic diarrhea (HP:0002028) | 2.20904479 |
| 96 | Keratoconjunctivitis (HP:0001096) | 2.20656040 |
| 97 | Increased IgE level (HP:0003212) | 2.20443471 |
| 98 | IgA deficiency (HP:0002720) | 2.19570343 |
| 99 | Encephalitis (HP:0002383) | 2.17666102 |
| 100 | Keratoconjunctivitis sicca (HP:0001097) | 2.17224906 |
| 101 | Increased serum lactate (HP:0002151) | 2.15153659 |
| 102 | Spontaneous hematomas (HP:0007420) | 2.12586807 |
| 103 | Oral leukoplakia (HP:0002745) | 2.12193457 |
| 104 | Skin ulcer (HP:0200042) | 2.11640270 |
| 105 | Abnormality of the pleura (HP:0002103) | 2.10608575 |
| 106 | Inflammation of the large intestine (HP:0002037) | 2.09540385 |
| 107 | Lactic acidosis (HP:0003128) | 2.08631812 |
| 108 | Type I transferrin isoform profile (HP:0003642) | 2.07901271 |
| 109 | Acute hepatic failure (HP:0006554) | 2.07706770 |
| 110 | Pulmonary fibrosis (HP:0002206) | 2.07251373 |
| 111 | Dicarboxylic aciduria (HP:0003215) | 2.05501423 |
| 112 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.05501423 |
| 113 | Pallor (HP:0000980) | 2.04505798 |
| 114 | Poor head control (HP:0002421) | 2.04035830 |
| 115 | Pancytopenia (HP:0001876) | 2.03131733 |
| 116 | Neutropenia (HP:0001875) | 2.02119266 |
| 117 | Abnormality of urine glucose concentration (HP:0011016) | 2.01452787 |
| 118 | Glycosuria (HP:0003076) | 2.01452787 |
| 119 | Osteomyelitis (HP:0002754) | 2.00947237 |
| 120 | Gastrointestinal inflammation (HP:0004386) | 2.00211484 |
| 121 | Gastrointestinal stroma tumor (HP:0100723) | 1.97532671 |
| 122 | Anorexia (HP:0002039) | 1.97191208 |
| 123 | Arterial thrombosis (HP:0004420) | 1.96845184 |
| 124 | Abnormality of the prostate (HP:0008775) | 1.94897255 |
| 125 | Gangrene (HP:0100758) | 1.94337492 |
| 126 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.91871896 |
| 127 | Hepatosplenomegaly (HP:0001433) | 1.91759960 |
| 128 | Nausea (HP:0002018) | 1.90834725 |
| 129 | Tetraparesis (HP:0002273) | 1.89080216 |
| 130 | Epistaxis (HP:0000421) | 1.88294759 |
| 131 | Bronchitis (HP:0012387) | 1.87693482 |
| 132 | Hypochromic anemia (HP:0001931) | 1.86044486 |
| 133 | Colitis (HP:0002583) | 1.85681082 |
| 134 | Prostate neoplasm (HP:0100787) | 1.84944110 |
| 135 | Skin rash (HP:0000988) | 1.82620978 |
| 136 | Arthralgia (HP:0002829) | 1.82575199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.10940444 |
| 2 | MAP3K14 | 4.10375991 |
| 3 | TBK1 | 3.39577512 |
| 4 | TYK2 | 3.36388891 |
| 5 | MAP4K1 | 3.07823097 |
| 6 | NME2 | 3.05980873 |
| 7 | IKBKE | 3.05814978 |
| 8 | JAK3 | 2.95413610 |
| 9 | IRAK4 | 2.76678112 |
| 10 | TXK | 2.76533330 |
| 11 | BLK | 2.64888895 |
| 12 | PIM2 | 2.54332243 |
| 13 | IKBKB | 2.43319870 |
| 14 | IRAK3 | 2.23092865 |
| 15 | PBK | 2.14746572 |
| 16 | ZAP70 | 2.10615545 |
| 17 | KIT | 1.99601483 |
| 18 | MST4 | 1.84641282 |
| 19 | JAK1 | 1.82734099 |
| 20 | FGFR4 | 1.77725622 |
| 21 | KDR | 1.69099884 |
| 22 | ERN1 | 1.63842567 |
| 23 | BTK | 1.59193705 |
| 24 | TEC | 1.56201373 |
| 25 | SYK | 1.53245091 |
| 26 | RPS6KA4 | 1.51593865 |
| 27 | CHUK | 1.51276145 |
| 28 | FES | 1.39564429 |
| 29 | TESK1 | 1.37470563 |
| 30 | SCYL2 | 1.33594410 |
| 31 | RIPK4 | 1.31726239 |
| 32 | PIM1 | 1.25115572 |
| 33 | MAPKAPK3 | 1.24250383 |
| 34 | CSK | 1.19941440 |
| 35 | NEK9 | 1.18649927 |
| 36 | DAPK1 | 1.18459255 |
| 37 | MAP3K13 | 1.17994104 |
| 38 | EIF2AK1 | 1.16503155 |
| 39 | LCK | 1.15007557 |
| 40 | ZAK | 1.07819684 |
| 41 | LRRK2 | 1.06906637 |
| 42 | LYN | 1.06027744 |
| 43 | TESK2 | 1.05566841 |
| 44 | NLK | 1.04804048 |
| 45 | NEK1 | 1.04635504 |
| 46 | CSF1R | 1.03656475 |
| 47 | GRK7 | 1.03054065 |
| 48 | EIF2AK2 | 0.98269083 |
| 49 | ITK | 0.97636305 |
| 50 | STK10 | 0.96795427 |
| 51 | MST1R | 0.96305947 |
| 52 | TAOK3 | 0.94948625 |
| 53 | ACVR1B | 0.91324794 |
| 54 | ARAF | 0.91144455 |
| 55 | FLT3 | 0.90210791 |
| 56 | EIF2AK3 | 0.89947534 |
| 57 | FGFR3 | 0.87371375 |
| 58 | SMG1 | 0.86669787 |
| 59 | JAK2 | 0.83965772 |
| 60 | ABL2 | 0.83677131 |
| 61 | HCK | 0.82854432 |
| 62 | STK4 | 0.82460786 |
| 63 | STK16 | 0.80245229 |
| 64 | LIMK1 | 0.78169442 |
| 65 | EPHB1 | 0.76532243 |
| 66 | TAF1 | 0.76325582 |
| 67 | GRK6 | 0.75474297 |
| 68 | SRPK1 | 0.74302579 |
| 69 | TAOK2 | 0.73982925 |
| 70 | TGFBR1 | 0.70533586 |
| 71 | EPHA3 | 0.68948087 |
| 72 | IRAK1 | 0.68904408 |
| 73 | MAP2K3 | 0.68254076 |
| 74 | CDK8 | 0.67376629 |
| 75 | TNK2 | 0.66232836 |
| 76 | MYLK | 0.65875149 |
| 77 | BMPR2 | 0.63983693 |
| 78 | PDK2 | 0.61262892 |
| 79 | MAP3K12 | 0.60988990 |
| 80 | PRKCD | 0.59518729 |
| 81 | BUB1 | 0.59386016 |
| 82 | RPS6KA5 | 0.56772943 |
| 83 | MAP3K11 | 0.55027521 |
| 84 | MAPKAPK2 | 0.54365425 |
| 85 | VRK1 | 0.53071282 |
| 86 | PRKCQ | 0.52927363 |
| 87 | MAP3K3 | 0.51994120 |
| 88 | MATK | 0.50999435 |
| 89 | TGFBR2 | 0.47880354 |
| 90 | BCKDK | 0.46723647 |
| 91 | MAP2K6 | 0.46700399 |
| 92 | GRK1 | 0.45475440 |
| 93 | ADRBK2 | 0.44710042 |
| 94 | DAPK3 | 0.43998299 |
| 95 | MARK3 | 0.43167489 |
| 96 | PRKG2 | 0.42120404 |
| 97 | TLK1 | 0.40914066 |
| 98 | PTK6 | 0.40722920 |
| 99 | ABL1 | 0.39815827 |
| 100 | OXSR1 | 0.39766463 |
| 101 | RPS6KA6 | 0.38541329 |
| 102 | PIK3CG | 0.38360751 |
| 103 | SIK3 | 0.37931410 |
| 104 | IGF1R | 0.36606612 |
| 105 | MAP2K2 | 0.35375158 |
| 106 | MAPK11 | 0.34586519 |
| 107 | CDK4 | 0.34190921 |
| 108 | MAPKAPK5 | 0.33479791 |
| 109 | CLK1 | 0.33092789 |
| 110 | CSNK2A1 | 0.32038388 |
| 111 | BCR | 0.30951662 |
| 112 | MAP3K8 | 0.30817974 |
| 113 | ILK | 0.30804865 |
| 114 | GRK5 | 0.30784415 |
| 115 | NME1 | 0.30621597 |
| 116 | RPS6KB2 | 0.30540447 |
| 117 | MUSK | 0.30255529 |
| 118 | FGR | 0.29301282 |
| 119 | MAP3K5 | 0.29050614 |
| 120 | PLK4 | 0.27677312 |
| 121 | PAK4 | 0.27503657 |
| 122 | BMPR1B | 0.27462465 |
| 123 | CSNK2A2 | 0.27345813 |
| 124 | YES1 | 0.27039387 |
| 125 | TRPM7 | 0.26877617 |
| 126 | STK24 | 0.26603476 |
| 127 | ATR | 0.26543863 |
| 128 | NUAK1 | 0.24247019 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.41578933 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.36026532 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.14296084 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.72358086 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.57065574 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.56911782 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.52646481 |
| 8 | * Proteasome_Homo sapiens_hsa03050 | 2.49440453 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.47458435 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.25403775 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.22030950 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.15619906 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.10619377 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.04480685 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.99734205 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.89799657 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.88258266 |
| 18 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81953356 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.79589609 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76557135 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.74643799 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.70624528 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.61719191 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.46667922 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.46271573 |
| 26 | DNA replication_Homo sapiens_hsa03030 | 1.40154413 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39339311 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.38871265 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33852441 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28336406 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.28251826 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.27267785 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.27254320 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22493582 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.22162393 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.21526768 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19167188 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.17166026 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.12332535 |
| 40 | Protein export_Homo sapiens_hsa03060 | 1.09057405 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.08748621 |
| 42 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01204007 |
| 43 | Base excision repair_Homo sapiens_hsa03410 | 0.97884079 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96818646 |
| 45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.94453590 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93589308 |
| 47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.93161829 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.89317943 |
| 49 | Mismatch repair_Homo sapiens_hsa03430 | 0.87891836 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87802686 |
| 51 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.85552454 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 0.85468071 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.84471154 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80511122 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.80104918 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80028026 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78075274 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76611438 |
| 59 | Homologous recombination_Homo sapiens_hsa03440 | 0.73708345 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71270220 |
| 61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70477884 |
| 62 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.69032866 |
| 63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68925799 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68249452 |
| 65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66819156 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66019814 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 0.65383466 |
| 68 | RNA polymerase_Homo sapiens_hsa03020 | 0.64571015 |
| 69 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64032971 |
| 70 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.62228129 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.61327655 |
| 72 | Lysosome_Homo sapiens_hsa04142 | 0.60638335 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59832550 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58402430 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57670792 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57300172 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57266988 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.55477297 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50895584 |
| 80 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49188332 |
| 81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48784879 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48541811 |
| 83 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.47744656 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47310479 |
| 85 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.47288462 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46164527 |
| 87 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45923318 |
| 88 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45020557 |
| 89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44974130 |
| 90 | RNA degradation_Homo sapiens_hsa03018 | 0.43961774 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43596250 |
| 92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.43357043 |
| 93 | Purine metabolism_Homo sapiens_hsa00230 | 0.43009015 |
| 94 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.42251536 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42055094 |
| 96 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42043614 |
| 97 | Spliceosome_Homo sapiens_hsa03040 | 0.41762112 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.41122566 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41106269 |
| 100 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39660484 |
| 101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39499255 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | 0.38879175 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.38514449 |
| 104 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.37862750 |
| 105 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.37151380 |
| 106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37103618 |
| 107 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.36734765 |
| 108 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35350319 |
| 109 | Peroxisome_Homo sapiens_hsa04146 | 0.34486082 |
| 110 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.34364130 |
| 111 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32714618 |
| 112 | Alzheimers disease_Homo sapiens_hsa05010 | 0.30963086 |
| 113 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30927447 |
| 114 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.30916215 |
| 115 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30335973 |
| 116 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.28769564 |
| 117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28535279 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.28394591 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.27979093 |
| 120 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.27959930 |
| 121 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.27906717 |
| 122 | Retinol metabolism_Homo sapiens_hsa00830 | 0.27798527 |
| 123 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.27472407 |
| 124 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.27214313 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26351604 |
| 126 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.25961656 |
| 127 | Huntingtons disease_Homo sapiens_hsa05016 | 0.25794157 |

